Innovita Biological Technology Co., Ltd. (SHA:688253)
China
· Delayed Price · Currency is CNY 34.80
+1.16 (3.45%)
Mar 6, 2026, 4:00 PM EST
SHA:688253 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | 246.86 | 173.95 | 150.68 | 120.25 | Upgrade
|
| Depreciation & Amortization | - | 21.71 | 25.46 | 19.06 | 13.21 | Upgrade
|
| Other Amortization | - | 7.98 | 7.46 | 6.66 | 5.89 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.01 | -0 | -0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.11 | 19.54 | - | 0.61 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -32.03 | -26.08 | -7.09 | -2.46 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 4.04 | 4.91 | 6.17 | - | Upgrade
|
| Other Operating Activities | - | 7.97 | 25.51 | 1.6 | 0.04 | Upgrade
|
| Change in Accounts Receivable | - | 47.27 | 48.71 | -193.74 | 18.62 | Upgrade
|
| Change in Inventory | - | 14.01 | -12.42 | -31.83 | -6.13 | Upgrade
|
| Change in Accounts Payable | - | -9.46 | 0.37 | 174.7 | -44.3 | Upgrade
|
| Change in Other Net Operating Assets | - | 6.15 | 1.72 | - | - | Upgrade
|
| Operating Cash Flow | - | 305.46 | 259.85 | 126.43 | 106.27 | Upgrade
|
| Operating Cash Flow Growth | - | 17.55% | 105.53% | 18.97% | -83.39% | Upgrade
|
| Capital Expenditures | - | -36.16 | -16.97 | -57.71 | -63.75 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.26 | 0 | - | 0 | Upgrade
|
| Investment in Securities | - | -26.11 | -410.95 | -1,037 | 22.78 | Upgrade
|
| Other Investing Activities | - | -1 | - | 8.82 | 1.7 | Upgrade
|
| Investing Cash Flow | - | -63.01 | -428.92 | -1,086 | -39.27 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 17.57 | - | Upgrade
|
| Total Debt Issued | - | - | - | 17.57 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -8.29 | Upgrade
|
| Long-Term Debt Repaid | - | -3.55 | -20.83 | -3.05 | -1.19 | Upgrade
|
| Total Debt Repaid | - | -3.55 | -20.83 | -3.05 | -9.48 | Upgrade
|
| Net Debt Issued (Repaid) | - | -3.55 | -20.83 | 14.52 | -9.48 | Upgrade
|
| Issuance of Common Stock | - | 5.25 | - | 820.07 | - | Upgrade
|
| Common Dividends Paid | - | -54.42 | -22.64 | -0.22 | -50.07 | Upgrade
|
| Other Financing Activities | - | -50.01 | -1 | -18.59 | - | Upgrade
|
| Financing Cash Flow | - | -102.74 | -44.48 | 815.78 | -59.55 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1.56 | 1.33 | 42.65 | -9.76 | Upgrade
|
| Net Cash Flow | - | 141.27 | -212.21 | -101.07 | -2.3 | Upgrade
|
| Free Cash Flow | - | 269.31 | 242.89 | 68.71 | 42.52 | Upgrade
|
| Free Cash Flow Growth | - | 10.88% | 253.47% | 61.59% | -92.45% | Upgrade
|
| Free Cash Flow Margin | - | 43.34% | 50.81% | 15.38% | 13.01% | Upgrade
|
| Free Cash Flow Per Share | - | 1.98 | 1.79 | 0.56 | 0.42 | Upgrade
|
| Cash Income Tax Paid | - | 90.94 | 45.98 | 33.76 | 42.72 | Upgrade
|
| Levered Free Cash Flow | - | 213.46 | 178.62 | 44.72 | -7.06 | Upgrade
|
| Unlevered Free Cash Flow | - | 213.54 | 178.75 | 44.97 | -6.98 | Upgrade
|
| Change in Working Capital | - | 48.84 | 29.1 | -50.64 | -31.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.